Search

everythinglearnresearchcommunity

for

Search:↓

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Some medicinal plants can help heal wounds and may lead to new treatments.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Individualized treatment and psychological support are crucial for alopecia.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Gynostemma pentaphyllum and its component damulin B could help hair grow by activating certain cell pathways.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Researchers found genes linked to feather growth speed in Shouguang chickens, highlighting two genes that might explain differences in feathering.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.